TITLE

Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis

AUTHOR(S)
Shah, Pallav L.; Hansell, David; Lawson, Peter R.; Reid, Kenneth B. M.; Morgan, Cliff
PUB. DATE
January 2000
SOURCE
Thorax;Jan2000, p67
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66313281

 

Related Articles

  • Pulmonary Alveolar Proteinosis. Trapnell, Bruce C.; Whitsett, Jeffrey A.; Nakata, Koh // New England Journal of Medicine;12/25/2003, Vol. 349 Issue 26, p2527 

    Discusses pulmonary alveolar proteinosis. Details of the three clinical forms of the disease; Natural history of cases regarding the disease; Treatment methods; Pathogenesis in humans; Results of testing and treatment on mice.

  • Answer to case of the month #71. Arzoumanian, Yervant; Chartrand-Lefebvre, Carl; Gariepy, Gilles; Dansereau, Jacques Albert // Canadian Association of Radiologists Journal;Feb2000, Vol. 51 Issue 1, p42 

    Presents a clinical case of a man with pulmonary alveolar proteinosis. Case report; Radiographic and histologic findings; Pathophysiology of the disease condition; Presenting signs and symptoms.

  • Relationship Between Diffuse Pulmonary Fibrosis, Alveolar Proteinosis, and Granulocyte-Macrophage Colony Stimulating Factor Autoantibodies. Luisetti, Maurizio; Bruno, Pierdonato; Kadija, Zamir; Suzuki, Takuji; Raffa, Salvatore; Torrisi, Maria Rosaria; Campo, Ilaria; Mariani, Francesca; Pozzi, Ernesto; Trapnell, Bruce C.; Mariotta, Salvatore // Respiratory Care;Oct2011, Vol. 56 Issue 10, p1608 

    Extensive pulmonary fibrosis is a rare occurrence in pulmonary alveolar proteinosis. We report 2 cases that have interesting implications. A female patient was diagnosed with autoimmune pulmonary alveolar proteinosis that evolved over 7 years into diffuse fibrosis. In a male patient with diffuse...

  • Pulmonary Alveolar Proteinosis. Knott, James L.; MacHaffie, Reginald A.; Lin, Tung K.; Loomis, George W.; Brody, Alfred W. // Annals of Internal Medicine;Sep61, Vol. 55 Issue 3, p481 

    Reports on a case of a 34-year-old white bakery routeman with pulmonary alveolar proteinosis. Medical history of the patient; Clinical manifestations of the disease; Methods of diagnosis and treatment.

  • Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. Ceruti, Michele; Rodi, Giuseppe; Stella, Giulia M.; Adami, Andrea; Bolongaro, Antonia; Baritussio, Aldo; Pozzi, Ernesto; Luisetti, Maurizio // Orphanet Journal of Rare Diseases;2007, Vol. 2, p14 

    Background: Pulmonary alveolar proteinosis (PAP) is a rare disease characterised by accumulation of lipoproteinaceous material within alveoli, occurring in three clinically distinct forms: congenital, acquired and secondary. Among the latter, lysinuric protein intolerance (LPI) is a rare genetic...

  • Congenital Pulmonary Alveolar Proteinosis. Hammami, Saber; Harrathi, Khaled; Lajmi, Khaled; Hadded, Samir; Ben Meriem, Chebil; Guédiche, Mohamed Néji // Case Reports in Pediatrics;2013, p1 

    Pulmonary alveolar proteinosis (PAP) is a rare syndrome characterized by pulmonary surfactant accumulation within the alveolar spaces. It occurs with a reported prevalence of 0.1 per 100,000 individuals. Two clinically different pediatric types have been defined as congenital PAP which is fatal...

  • Ciclosporin/mycophenolate.  // Reactions Weekly;10/13/2012, Issue 1423, p16 

    The article describes the case of a woman who developed pulmonary alveolar proteinosis (PAP) during treatment with ciclosporin and mycophenolate combination therapy.

  • Sirolimus.  // Reactions Weekly;9/4/2010, Issue 1317, p41 

    The article describes the case of a woman who developed pulmonary alveolar proteinosis during treatment with sirolimus.

  • GM-CSF and proteinosis. Khanjari, F.; Watier, H.; Domenech, J.; Asquier, E.; Diot, P.; Nakata, K. // Thorax;Jul2003, Vol. 58 Issue 7, p645 

    Reports on the use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in the treatment of pulmonary alveolar proteinosis (PAP) in patient with no GM-CSF antibodies. Role of GM-CSF production defect in the pathogenesis of PAP.

  • The Association of Nocardiosis and Pulmonary Alveolar Proteinosis. Andriole, Vincent T.; Ballas, Maurice; Wilson, George L. // Annals of Internal Medicine;Feb64 Part 2, Vol. 60 Issue 2, p266 

    Describes the case of a patient with pulmonary alveolar proteinosis and nocardiosis with dissemination to the skin and brain. Illustration of the phases and progress of the conditions; Indications of increased susceptibility to pulmonary infections.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics